Antiplatelet therapy after transcatheter aortic valve implantation: a systematic review and meta-analysis.
Gonçalo Nuno Ferraz CostaMarco CostaLino GonçalvesRogerio TeixeiraPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2021)
Our pooled analysis suggests that for patients who underwent TAVI, double antiplatelet therapy compared with single antiplatelet therapy alone increased the risk of bleeding without reducing mortality and ischaemic events.
Keyphrases
- antiplatelet therapy
- transcatheter aortic valve implantation
- acute coronary syndrome
- percutaneous coronary intervention
- aortic stenosis
- aortic valve
- ejection fraction
- aortic valve replacement
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- coronary artery disease
- transcatheter aortic valve replacement
- peritoneal dialysis
- cardiovascular events
- heart failure